{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-012538","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2026-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.171694+00:00","generated_at":"2026-05-15T07:57:01.170782+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Femasys appoints John Canning as COO; base $450K, inducement option 150K shares","bullets":["John Canning appointed COO effective March 30, 2026; annual base salary $450,000 with 40% target bonus.","Canning previously COO at Terumo Aortic (2017-2026) and Bolton Medical, with 25+ years MedTech experience.","Granted inducement stock option for 150,000 shares at closing price on grant date; vesting 25% annually over 4 years.","Appointment aims to strengthen operational capabilities and support commercial growth of FemBloc and FemaSeed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-012538","json":"https://secwatch.observer/filing/0001140361-26-012538.json","markdown":"https://secwatch.observer/filing/0001140361-26-012538.md","text":"https://secwatch.observer/filing/0001140361-26-012538.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126012538/0001140361-26-012538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126012538/ef20069522_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:57:01.170782+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}